We believe in patient-driven decisions and educating our patients
In glycemic control clinical trials, the risk of hypoglycemia was increased when semaglutide injection was used concomitantly with insulin or an insulin secretagogue (e.g., sulfonylurea)
Timing: Any steady weekly schedule works
Results demonstrated that continuous therapy produced sustained weight reduction, with participants maintaining an average of 1522% body weight loss compared to placebo
Although preliminary evidence suggests potential benefits for sports performance, oxidative stress reduction, and cognitive function, most studies are small-scale, preclinical, or observational
Lilly seems relieved and hopeful